| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |